Principal Scientist, Ihc Sme; Clinical Measurement Sciences, Clinical Biomarkers And Technologies
CurrentManagement of pathology projects for early and late stage clinical trials; provides expert knowledge as required for in situ biomarker analysis in late discovery, clinical development, CDx and market enabling activities; project management of IHC assay development through clinical development life-cycle by external vendors